Harte Hanks (HHS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Q4 2024 revenue was $47.1M, down 4.8% year-over-year; full-year revenue was $185.2M, down 3.3%.
Q4 net loss was $2.4M ($0.33/share) vs. $2.0M loss ($0.27/share) in Q4 2023; full-year net loss was $30.3M, mainly due to $37.5M pension plan termination charges.
Ended 2024 with $9.9M cash, zero debt, and a fully terminated Pension Plan I.
Project Elevate continued to optimize cost structure and streamline operations.
Financial highlights
Q4 operating loss improved to $1.6M from $2.3M in Q4 2023.
Q4 EBITDA was negative $0.3M vs. negative $1.1M in Q4 2023; Adjusted EBITDA was $3.5M vs. $5.2M.
Full-year operating income was $2.1M, down 37.7% from $3.4M in 2023.
Adjusted operating margin for 2024 was 5.2%, down from 6.4% in 2023.
Outlook and guidance
Positioned for future growth in 2025 and beyond, with strong liquidity and no debt.
Project Elevate initiatives to continue addressing business-critical needs and innovation.
Latest events from Harte Hanks
- Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 202518 Mar 2026 - Q2 net loss of $27.8M from pension charge; Sales Services surged, cash strong, no debt.HHS
Q2 20242 Feb 2026 - Q3 revenue up 1.1% YoY; profit metrics declined; Q4 revenue expected to contract.HHS
Q3 202414 Jan 2026 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing2 Dec 2025 - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing2 Dec 2025 - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 202512 Nov 2025 - Revenue dropped 14.2% but net loss narrowed and EBITDA stayed positive in Q2 2025.HHS
Q2 20258 Aug 2025 - Revenue fell 8.6% to $41.6M, net loss widened, but liquidity and new business remain strong.HHS
Q1 20256 Jun 2025